Phosphate binders in CKD: bad news or good news?
Tilman B
TB
Drüeke
Ziad A
ZA
Massy
D000085:Acetates / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D054559:Hyperphosphatemia / Q000517:prevention & control*; D007811:Lanthanum / Q000627:therapeutic use*; D008297:Male; D011073:Polyamines / Q000627:therapeutic use*; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D000069603:Sevelamer
D000085:Acetates; D017610:Calcium Compounds; D002614:Chelating Agents; D011073:Polyamines; C119467:lanthanum carbonate; D007811:Lanthanum; D000069603:Sevelamer; C120662:calcium acetate